Toggle navigation
Home
Search
Services
Blog
Contact
About
Predicting Immunologically Mediated Adverse Reactions
Smith, Mark
Imbic, Inc., Columbia, MO, United States
Search 169 grants from Mark Smith
Search grants from Imbic, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulation of Neuromyelitis Optica via Tolerance Induced by PLG Nanoparticles Encapsulating Aquaporin 4 Epitopes
Exploring a role for organic transporter 3 in the mechanism of action of drugs of abuse
A Cross-Country Comparison of Evidence-Based Prevention of Cancer
CORE - Data Management
The involvement of LIM kinase in metastases
Recently added grants:
A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells
Drug overdose out-of-hospital cardiac arrest events in the United States: Insights from a large data registry
Re-engineered Mitochondrially Targeted p53 Gene Therapy in Liver Cancer
Nociceptor neuron regulation of gastrointestinal barrier protection and host defense
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43AI052596-002
Application #
3594772
Study Section
Project Start
1985-08-01
Project End
Budget Start
1985-09-03
Budget End
1986-01-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Imbic, Inc.
Department
Type
DUNS #
City
Columbia
State
MO
Country
United States
Zip Code
65205
Related projects
NIH 1985
N43 AI
Predicting Immunologically Mediated Adverse Reactions
Smith, Mark / Imbic, Inc.
NIH 1985
N43 AI
Predicting Immunologically Mediated Adverse Reactions
Smith, Mark / Imbic, Inc.
Comments
Be the first to comment on this grant